Tutorials
Amphastar Pharmaceuticals Inc logo

Amphastar Pharmaceuticals Inc

$ 31.62 +0.3 (+0.96%) 08:08 PM EST
P/E:
17.76
P/B:
3.10
Market Cap:
$ 1.55B
Enterprise V:
$ 1.47B
Volume:
416.34K
Avg Vol (2M):
435.06K
Also Trade In:
Volume:
416.34K
Market Cap $:
1.55B
PE Ratio:
17.76
Avg Vol (2-Month):
435.06K
Enterprise Value $:
1.47B
PB Ratio:
3.10
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Amphastar Pharmaceuticals Inc
NAICS : 325412 SIC : 2834
11570 6th Street, Rancho Cucamonga, CA, USA, 91730
Description
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling technically-challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.
Name Current Vs Industry Vs History
Cash-To-Debt 1.77
Equity-to-Asset 0.69
Debt-to-Equity 0.21
Debt-to-EBITDA 0.72
Interest Coverage 65.97
Piotroski F-Score 7/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 6.23
Distress
Grey
Safe
Beneish M-Score -2.45
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 19.11
9-Day RSI 25.29
14-Day RSI 32.57
6-1 Month Momentum % 31.98
12-1 Month Momentum % 83.41

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.64
Quick Ratio 2.69
Cash Ratio 1.77
Days Inventory 141.4
Days Sales Outstanding 57.98
Days Payable 36.9

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -0.8

Financials (Next Earnings Date:2022-11-08 Est.)

AMPH's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:AMPH

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 476.92
EPS (TTM) ($) 1.78
Beta 0.49
Volatility % 40.04
14-Day RSI 32.57
14-Day ATR ($) 1.753624
20-Day SMA ($) 35.8525
12-1 Month Momentum % 83.41
52-Week Range ($) 17.56 - 44.46
Shares Outstanding (Mil) 49.02

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 7
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Amphastar Pharmaceuticals Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More